blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4125879

EP4125879 - METHODS OF TREATING PROTEINOPATHY- ASSOCIATED WANDERING [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.01.2023
Database last updated on 09.09.2024
FormerThe international publication has been made
Status updated on  08.06.2022
Most recent event   Tooltip02.03.2024Supplementary search reportpublished on 03.04.2024  [2024/14]
Applicant(s)For all designated states
Woolsey Pharmaceuticals, Inc.
7901 4th Street N, Suite 6987
St. Petersburg, FL 33702 / US
[2023/06]
Inventor(s)01 / MACALLISTER, Thomas
1201 N Garfield St. 319
Arlington, Virginia 22201 / US
02 / JACOBSON, Sven
37 Wall St 16B
New York, New York 10005 / US
 [2023/06]
Representative(s)Canet, Denis
DC IP Services
52, boulevard de Sébastopol
75003 Paris / FR
[2023/06]
Application number, filing date21776897.708.01.2021
[2023/06]
WO2021US12587
Priority number, dateUS202062994527P25.03.2020         Original published format: US 202062994527 P
US202063005913P06.04.2020         Original published format: US 202063005913 P
[2023/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021194608
Date:30.09.2021
Language:EN
[2021/39]
Type: A1 Application with search report 
No.:EP4125879
Date:08.02.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 30.09.2021 takes the place of the publication of the European patent application.
[2023/06]
Search report(s)International search report - published on:US30.09.2021
(Supplementary) European search report - dispatched on:EP01.03.2024
ClassificationIPC:A61K31/551, A61K31/407, A61K31/4725, A61P25/28
[2024/14]
CPC:
A61P25/28 (EP,US); A61K31/551 (EP,US)
Former IPC [2023/06]A61K31/407, A61K31/4725, A61K31/551, A61P25/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/06]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON MIT PROTEINOPATHIE ASSOZIIERTEM WANDERN[2023/06]
English:METHODS OF TREATING PROTEINOPATHY- ASSOCIATED WANDERING[2023/06]
French:MÉTHODES DE TRAITEMENT DE LA DÉSORIENTATION SPATIO-TEMPORELLE ASSOCIÉE À UNE PROTÉINOPATHIE[2023/06]
Entry into regional phase19.10.2022National basic fee paid 
19.10.2022Search fee paid 
19.10.2022Designation fee(s) paid 
19.10.2022Examination fee paid 
Examination procedure19.10.2022Examination requested  [2023/06]
15.05.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
19.10.2022Renewal fee patent year 03
08.01.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2021142183  (WOOLSEY PHARMACEUTICALS INC [US]) [E] 1-16 * abstract * * page 7, line 30 - page 9, line 18 * * page 11, line 5 - page 12, line 12 * * page 18, line 7 - page 22, line 3 * * page 28, line 2 - page 29, line 9 * * page 32, line 1 - line 11 * * example 1 * * claims 1-17 *;
 [E]WO2021216139  (WOOLSEY PHARMACEUTICALS INC [US]) [E] 1-16 * abstract * * page 4, line 26 - page 7, line 15 * * page 7, line 17 - line 25 * * page 8, line 1 - page 10, line 9 * * page 14, line 28 * * page 18, line 18 - line 25 * * page 19, line 16 - page 20, line 2 * * page 22, line 14 - line 20 * * Example * * claims 1-9 *;
 [E]WO2022015365  (WOOLSEY PHARMACEUTICALS INC [US]) [E] 1-16 * abstract * * page 2, line 15 - page 4, line 1 * * page 8, line 1 - page 9, line 3 * * page 9, line 15 - page 12, line 7 * * page 24, line 3 - line 26 ** claims 1-19 *;
 [X]  - GENTRY E. G. ET AL, "Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration", THE JOURNAL OF NEUROSCIENCE, US, (20160127), vol. 36, no. 4, doi:10.1523/JNEUROSCI.2336-15.2016, ISSN 0270-6474, pages 1316 - 1323, XP055935778 [X] 1,3-16 * the whole document *

DOI:   http://dx.doi.org/10.1523/JNEUROSCI.2336-15.2016
International search[Y]US2009318485  (BORCHARDT ALLEN J [US], et al) [Y] 18* ; para [0103] *;
 [XY]  - Turk Mari; Kusumi Kenro; Co-Chair; Huentelman Matthew; Co-Chair; Jensen Kendall; Stabenfeldt Sarah, "The Effect of Rho Kinase Inhibitors on Alzheimer's Disease.", ProQuest Dissertations Publishing, (20170500), pages 1 - 149, URL: https://repository.asu.edu/attachments/186373/content/Turk_asu_0010E_16879.pdf, (20210305), XP055840490 [X] 1-5, 10-11, 14-15, 17, 19- 20 * ; pg 8, para 2; pg 9, para 3; pg 10, para 1; pg 32, para 1; pg 56, para 2 * [Y] 6-9, 12-13, 16, 18
 [Y]  - KAMEI et al., "Evaluation of fasudil hydrochloride treatment for wandering symptoms in cerebrovascular dementiawith 31 P-magnetic resonance spectroscopy and Xe-computed tomography", Clinical Neuropharmacology, (19961000), vol. 19, no. 5, pages 428 - 438, XP008046435 [Y] 6, 13 * ; abstract *
 [Y]  - ALGASE et al., "Biomechanical activity devices to index wandering behavior in dementia", American Journal of Alzheimer's Disease and Other Dementias, (20030000), vol. 18, no. 2, pages 85 - 92, XP055864098 [Y] 7 * ; pg 91, col 1, para 5 *
 [Y]  - Pai Ming-Chyi, Jacobs W. Jake, "Topographical disorientation in community-residing patients with Alzheimer's disease", International Journal of Geriatric Psychiatry, (20040216), vol. 19, no. 3, pages 250 - 255, XP055864102 [Y] 8 * ; pg 253, col 1, para 2 *

DOI:   http://dx.doi.org/10.1002/gps.1081
 [Y]  - Jo Kyunghwa, Jhoo Jin Hyeong, Mun Young-Ju, Kim Yeon Mi, Kim Sung Keun, Kim Seongheon, Lee Seung-Hwan, Jang Jae-Won, "The Effect of Cognitive Intervention on Cognitive Improvement in Patients with Dementia", Dementia and Neurocognitive Disorder, (20180000), vol. 17, no. 1, pages 23 - 31, XP055864104 [Y] 9, 12-13 * ; abstract *

DOI:   http://dx.doi.org/10.12779/dnd.2018.17.1.23
 [Y]  - VICARI et al., "Efficacy and Safety of Fasudil in Patients With Stable Angina A Double-Blind, Placebo-Controlled, Phase 2 Trial", Journal of the American College of Cardiology, (20051115), vol. 46, no. 10, doi:10.1016/j.jacc.2005.07.047, pages 1803 - 1811, XP029656529 [Y] 16 * ; pg 18504, col 1, para 2 *

DOI:   http://dx.doi.org/10.1016/j.jacc.2005.07.047
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.